XML 17 R6.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income (loss) $ (658,967) $ (395,999)
Adjustments to net income (loss):    
Depreciation and amortization 645,045 650,280
Deferred income tax expense (benefit) 24,535 14,565
Impairments and other charges 301,619 98,869
Amortization of debt discount and deferred financing costs 24,347 23,197
Losses (gains) on debt buyback (65,848) 1,752
Losses (gains) on long-lived assets, net 5,754 8,410
Losses (gains) on investments, net 5,653 (2,400)
Provision (recovery) of bad debt 9,729 379
Share-based compensation 20,170 19,489
Foreign currency transaction losses (gains), net 11,404 18,681
Noncontrolling interest (38,437) (44,202)
Other 257 511
Changes in operating assets and liabilities, net of effects from acquisitions:    
Accounts receivable 90,757 136,266
Inventory 11,111 (21,500)
Other current assets 12,510 18,085
Other long-term assets 22,907 (37,977)
Trade accounts payable and accrued liabilities (159,621) (129,375)
Income taxes payable 2,393 3,459
Other long-term liabilities (17,412) 68,338
Net cash provided by (used for) operating activities 247,906 430,828
Cash flows from investing activities:    
Purchases of investments (30) (5,008)
Sales and maturities of investments 2,043 14,466
Cash paid for acquisition of businesses, net of cash acquired   (2,929)
Capital expenditures (153,128) (366,594)
Proceeds from sales of assets and insurance claims 21,773 26,365
Net cash (used for) provided by investing activities (129,342) (333,700)
Cash flows from financing activities:    
Proceeds from issuance of long-term debt 1,000,000  
Reduction in long-term debt (1,390,236) (379,193)
Debt issuance costs (19,149) (48)
Proceeds from revolving credit facilities 1,522,265 975,000
Reduction in revolving credit facilities (1,125,000) (690,000)
Proceeds from (payments for) short-term borrowings   497
Repurchase of common and preferred shares (13,858) (79)
Dividends to common and preferred shareholders (18,885) (41,643)
Distributions to noncontrolling interest (2,033) (4,552)
Other (1,576) (1,741)
Net cash (used for) provided by financing activities (48,472) (141,759)
Effect of exchange rate changes on cash and cash equivalents (3,987) (4,421)
Net increase (decrease) in cash and cash equivalents and restricted cash 66,105 (49,052)
Cash and cash equivalents and restricted cash, beginning of period 442,038 451,080
Cash and cash equivalents and restricted cash, end of period 508,143 402,028
RECONCILIATION OF CASH AND CASH EQUIVALENTS AND RESTRICTED CASH    
Cash and cash equivalents, beginning of period 435,990 447,766
Restricted cash, beginning of period 6,048 3,314
Cash and cash equivalents and restricted cash, beginning of period 442,038 451,080
Cash and cash equivalents, end of period 504,985 396,937
Restricted cash, end of period 3,158 5,091
Cash and cash equivalents and restricted cash, end of period $ 508,143 $ 402,028